Skip to main content
Year archive

STARSOURCE MULTITRADE LIMITED — 2022 filings

All 40 regulatory filings released by STARSOURCE MULTITRADE LIMITED (506365) in 2022, sourced directly from the official regulator.

40 Filings
2022 Period
2022 filings (40)
Filing Released Lang
Intimation of Trading Window Closure
Regulatory Filings
2022-12-29 English
Appointment of Mr. Ashok Somani, Director as Compliance Officer of the Company with effect from December 26, 2022.
Board/Management Information
2022-12-26 English
Attached
Regulatory Filings
2022-12-26 English
1. Considered and approved the resignation of Ms. Neha Vora as a Company Secretary and Compliance Officer of the Company with effect from December 15, 2022; 2. Approved the appointment ....
Board/Management Information
2022-12-26 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/12/2022 ,inter alia, to consider and approve 1. To take on record ....
Regulatory Filings
2022-12-21 English
With reference to the captioned subject, this is to inform you that Ms. Neha Vora, an Associate Member of the Institute of Company Secretaries of India having membership no. A30747, has ....
Regulatory Filings
2022-12-15 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
Regulatory Filings
2022-12-08 English
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of the newspaper ....
Regulatory Filings
2022-10-21 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
Regulatory Filings
2022-10-20 English
Approval of Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2022 along with the Limited Review Report thereon.
Regulatory Filings
2022-10-20 English
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the ....
Regulatory Filings
2022-10-20 English
Intimation regarding the issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
Regulatory Filings
2022-10-14 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2022 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings
2022-10-13 English
Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate for the quarter ....
Regulatory Filings
2022-10-03 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
Regulatory Filings
2022-09-29 English
Pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 and Company's Code of Conduct to Regulate, Monitor and Report Trading ....
Regulatory Filings
2022-09-28 English
Voting Results and Scrutinizer's Report of the 80TH Annual General Meeting as per Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements), 2015
Declaration of Voting Results & Voting Rights Announcements
2022-09-10 English
Proceedings/Outcome of the 80th Annual General Meeting as per Regulation 30 Read With Schedule III of SEBI (Listing Obligations and Disclosure Requirements), 2015
AGM Information
2022-09-08 English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015
Regulatory Filings
2022-08-22 English
Please find enclosed herewith a copy of Newspaper Advertisement published on August 12, 2022 in Business Standard (English) and Mumbai Lakshawadeep (Marathi) regarding the "Notice of 80" ....
Regulatory Filings
2022-08-12 English
This is to inform that the 80th Annual General Meeting (AGM) of the Company is scheduled to be held on Thursday, September 08, 2022 at 04:00 p.m. at the Registered Office of the Company ....
Regulatory Filings
2022-08-12 English
This is to inform you that Register of Members (Share Transfer Book) will be closed pursuant to the Regulation 42(2) to (4) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, ....
Regulatory Filings
2022-07-28 English
Approval of Un-Audited Financial Results of the Company for the quarter ended June 30, 2022 along with the Limited Review Report thereon.
Regulatory Filings
2022-07-28 English
1. Approval of Un-Audited Financial Results of the Company for the quarter ended June 30, 2022 along with the Limited Review Report thereon. 2. Approval of the Notice of the 80th Annual ....
Regulatory Filings
2022-07-28 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2022 ,inter alia, to consider and approve 1. To consider and ....
Regulatory Filings
2022-07-20 English
Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate for the quarter ....
Regulatory Filings
2022-07-04 English
Pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 and Company's Code of Conduct to Regulate, Monitor and Report Trading ....
Regulatory Filings
2022-06-30 English
Audited Standalone Financial Results Of The Company, For The Quarter And Year Ended March 31, 2022
Regulatory Filings
2022-05-27 English
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the ....
Regulatory Filings
2022-05-27 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 ,inter alia, to consider and approve 1. To consider and ....
Regulatory Filings
2022-05-17 English
Pursuant to above and based on the intimation received from the Company''s Registrar and Share Transfer Agent ("RTA") Purva Sharegistry (India) Private Limited on April 18, 2022, we would ....
Regulatory Filings
2022-04-18 English
We hereby submit Compliance Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2022.
Regulatory Filings
2022-04-18 English
Non-Applicability of Annual Secretarial Compliance Report for the year ended March 31, 2022 under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015
Regulatory Filings
2022-04-07 English
Please find enclosed compliance certificate for the financial year ended 31st March, 2022 pursuant to Regulation 7(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, ....
Regulatory Filings
2022-04-07 English
Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate for the quarter ....
Regulatory Filings
2022-04-05 English
Pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 and Company's Code of Conduct to Regulate, Monitor and Report Trading ....
Regulatory Filings
2022-03-31 English
Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31.12.2021
Regulatory Filings
2022-01-28 English
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors of the ....
Regulatory Filings
2022-01-28 English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 ,inter alia, to consider and approve the Un-Audited Financial ....
Regulatory Filings
2022-01-13 English
Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate for the quarter ended ....
Regulatory Filings
2022-01-04 English